What's New


License agreement with Univercell-Biosolutions S.A.S

iPS Academia Japan Inc. has concluded a worldwide non-exclusive license agreement with Univercell-Biosolutions S.A.S under the basic patents related to the iPS cell technology which we have been granted a licensing right by Kyoto University.

This license agreement enables Univercell-Biosolutions S.A.S to provide iPS cell derived cardiac cells to the pharmaceutical industry as a research tool. This is the third license agreement concluded with European companies in the field of research tool, following the preceding license agreements concluded with other German and French companies.

Univercell-Biosolutions S.A.S

Back to top